Get the Stockscreener App
0.96
2.19%
-0.0215
After Hours:
.97
0.01
+1.04%
Tela Bio Inc stock is traded at $0.96, with a volume of 43,949.
It is down -2.19% in the last 24 hours and down -23.81% over the past month.
TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
See More
Previous Close:
$0.9815
Open:
$0.96
24h Volume:
43,949
Relative Volume:
0.36
Market Cap:
$43.34M
Revenue:
$80.28M
Net Income/Loss:
$-38.83M
P/E Ratio:
-1.1541
EPS:
-0.8318
Net Cash Flow:
$-28.67M
1W Performance:
-11.93%
1M Performance:
-23.81%
6M Performance:
+20.05%
1Y Performance:
-35.14%
1-Day Range:
$0.96
$1.0899
1-Week Range:
$0.96
$1.09
52-Week Range:
$0.5011
$1.505
Tela Bio Inc Stock (TELA) Company Profile
Name
Tela Bio Inc
Sector
Industry
Phone
484-320-2930
Address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.96 | 43.34M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
103.10 | 178.40B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.95 | 120.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
301.42 | 115.62B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.06 | 65.30B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.82 | 52.35B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-25-26 | Initiated | Craig Hallum | Buy |
| Mar-21-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-31-22 | Initiated | Lake Street | Buy |
| Dec-03-19 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-19 | Initiated | Jefferies | Buy |
| Dec-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Tela Bio Inc Stock (TELA) Latest News
Form 4 Tela Bio Inc: Joseph H. Capper (Director) For: 15 October By Investing.com - Investing.com South Africa
Form 4 Tela Bio Inc: William J. Plovanic (Director) For: 15 October - Investing.com Canada
Form 4 Tela Bio Inc: Joseph H. Capper (Director) For: 15 October - Investing.com UK
Stock replaces cash pay for TELA Bio (TELA) director in 19,801-share award. - Stock Titan
TELA Bio (TELA) director William J. Plovanic receives 16,089 shares instead of cash compensation. - Stock Titan
TELA Bio Regains Nasdaq Compliance, Securing Listing Status - The Globe and Mail
TELA Bio Achieves Nasdaq Minimum Bid Price Compliance, Listing Issue Resolved - Kalkine Media
TELA Bio regains Nasdaq Global Market minimum bid price compliance - TradingView
TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement - GlobeNewswire Inc.
TELA Bio Faces Nasdaq Delisting, Plans Reverse Split - TipRanks
TELA Bio (TELA) director buys shares outside trading plan - Stock Titan
TELA Bio Received Notice of Delisting - TradingView
Tela Bio director Capper acquires $78,442 in company stock By Investing.com - Investing.com UK
Tela Bio director Capper acquires $78,442 in company stock - Investing.com
TELA Bio (TELA) director adds to stake in open-market buys - Stock Titan
Reverse split of up to 1-for-15 heads to a vote at TELA Bio (NASDAQ: TELA) after Nasdaq bid-price warning - Stock Titan
TELA Bio Inc. (TELA) Edges Higher on Renewed Buying Interest Near Key Support ZoneMoving Average Crossovers - dars.gov.et
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com South Africa
TELA Bio Cuts 41 Jobs as Losses Pressure Cash Position - MyChesCo
Malvern's TELA Bio Cuts Costs 18% and Parts Ways With Longtime COO/CFO Roberto Cuca - BioBuzz
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com Nigeria
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com Australia
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com Canada
Tela Bio CEO Heather Getz buys $8,311 in company stock - Investing.com
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com India
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com UK
TELA Bio Announces $17 Million Annual Cost Reduction and CFO Change Amid Restructuring - Kalkine Media
TELA Bio Cuts Annual Costs by $17 Million as COO-CFO Departs - citybiz
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com India
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com Canada
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com South Africa
TELA Looks 52.3% Undervalued on GF Value™ Despite Operational Ch - GuruFocus
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com Nigeria
TELA Bio Implements Workforce Cuts and Leadership Changes - TipRanks
TELA Bio cuts 20% of workforce to reduce costs by $17M annually - Investing.com UK
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative - GlobeNewswire
TELA Bio is cutting about 20% of its headcount to save $17 million a year - Stock Titan
Tela Bio Inc (TELA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Tela Bio CEO Heather Getz buys $8,311 in company stock - Investing.com
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com Canada
Tela Bio CEO Heather Getz buys $8,311 in company stock By Investing.com - Investing.com Nigeria
TELA Bio (TELA) CEO adds 12,500 shares in August buy - Stock Titan
TELA Bio (TELA) Q2 2026 Earnings Call Transcript - AOL.com
TELA (TELA) Quarter in Focus: The EPS Result Is Below Expectation under the Current Snapshot; Market Response: The Share Price Sheds 1.08% in the Available RecordProduct Revenue Analysis - vinanet.vn
TELA (TELA) Close and Levels: Ends Lower by 1.54% at $0.64 in the Latest Session; Chart Reference: the $0.61 to $0.67 Range Remains in Focus on the DayKAMA Signal - vinanet.vn
TELA (TELA) Close and Levels: Ends Lower by 1.54% at $0.64 in the Latest Session; Chart Reference: the $0.61 to $0.67 Range Remains in Focus on the DayChandelier Stop - siam.in
SILVERARC CAPITAL MANAGEMENT, LLC Trims TELA Bio Inc (TELA) Stake -- Shares Trade 55% Below GF Value - GuruFocus
TELA Bio (TELA) CEO buys 15,000 shares at $0.6978 - Stock Titan
Tela Bio Earnings Call: Growth Meets Execution Risks - TipRanks
Tela Bio Inc Stock (TELA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tela Bio Inc Stock (TELA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Capper Joseph H | Director |
Sep 17 '26 |
Buy |
1.22 |
25,000 |
30,530 |
179,827 |
| Capper Joseph H | Director |
Sep 15 '26 |
Buy |
1.06 |
50,000 |
52,940 |
104,827 |
| Capper Joseph H | Director |
Sep 14 '26 |
Buy |
1.02 |
25,000 |
25,502 |
54,827 |
| Getz Heather C | Chief Executive Officer |
Aug 17 '26 |
Buy |
0.66 |
12,500 |
8,311 |
532,500 |
| Getz Heather C | Chief Executive Officer |
Aug 14 '26 |
Buy |
0.70 |
15,000 |
10,467 |
520,000 |
| EW HEALTHCARE PARTNERS FUND 2, | 10% Owner |
Nov 17 '25 |
Buy |
1.11 |
3,604,000 |
4,000,440 |
7,714,709 |
1.18%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):